TABLE 3.

GSEA results.

ID	Description	setSize	Enrichment score	Adj. P-value
hsa05168	Herpes simplex virus 1 infection	467	0.284718529	8.72 × 10–5
hsa05022	Pathways of neurodegeneration	434	−0.333872677	9.04 × 10–5
hsa05010	Alzheimer’s disease	345	−0.318194061	3.88 × 10–3
hsa05014	Amyotrophic lateral sclerosis	320	−0.335493776	9.26 × 10–4
hsa05016	Huntington disease	269	−0.363160142	3.04 × 10–4
hsa05020	Prion disease	240	−0.398580749	3.67 × 10–5
hsa05012	Parkinson’s disease	232	−0.41709762	4.81 × 10–5
hsa04024	cAMP signaling pathway	217	−0.315166868	4.24 × 10–2
hsa03010	Ribosome	131	−0.360481409	4.24 × 10–2
hsa00190	Oxidative phosphorylation	103	−0.505392372	2.21 × 10–5
hsa04350	TGF-beta signaling pathway	92	0.417938926	1.33 × 10–3
hsa04911	Insulin secretion	86	−0.432626299	1.24 × 10–2
hsa04512	ECM-receptor interaction	86	0.363314004	4.22 × 10–2
hsa04260	Cardiac muscle contraction	81	−0.4123577	3.67 × 10–2
hsa04721	Synaptic vesicle cycle	78	−0.562303369	4.81 × 10–6
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	68	−0.44664597	2.13 × 10–2
hsa05110	Vibrio cholerae infection	49	−0.547099768	1.48 × 10–3
hsa00620	Pyruvate metabolism	46	−0.496786058	2.67 × 10–2
hsa03050	Proteasome	45	−0.530909935	4.32 × 10–3
hsa00020	Citrate cycle (TCA cycle)	30	−0.6441294	1.17 × 10–3
hsa04966	Collecting duct acid secretion	27	−0.577941421	2.69 × 10–2